Meta <META.O>: Wedbush Cuts Target Price to $595 From $671
META•Related News
Nuwellis says study backs epoprostenol as alternative anticoagulant for pediatric Aquadex ultrafiltration therapy
NUWE•
Piper Sandler declares quarterly dividend of $0.20 per share
PIPR•
Aligos Therapeutics to report Q2 2026 financial results
ALGS•
Lam Research Corp. <LRCX.O>: BofA Global Research cuts price objective to $385.00 from $480.00
LRCX•
Ramaco Resources publishes update to financial calendar
METC•